Surgepays Historical Income Statement
| SURG Stock | USD 3.98 0.20 4.78% |
Historical analysis of Surgepays income statement accounts such as Operating Income of 19.8 M, Ebit of 19.8 M, EBITDA of 21 M or Total Operating Expenses of 16.5 M can show how well Surgepays performed in making a profits. Evaluating Surgepays income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Surgepays's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Surgepays latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgepays is a good buy for the upcoming year.
Surgepays |
About Surgepays Income Statement Analysis
Surgepays Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Surgepays shareholders. The income statement also shows Surgepays investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Surgepays Income Statement Chart
Surgepays Income Statement is one of the three primary financial statements used for reporting Surgepays's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Surgepays revenue and expense. Surgepays Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Surgepays' Selling General Administrative is most likely to increase significantly in the upcoming years. The Surgepays' current Other Operating Expenses is estimated to increase to about 124.2 M, while Income Tax Expense is forecasted to increase to (2.2 M). Add Fundamental
Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Surgepays. It is also known as Surgepays overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Total Revenue
Total revenue comprises all receipts Surgepays generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most accounts from Surgepays' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Selling General Administrative is most likely to increase significantly in the upcoming years. The Surgepays' current Other Operating Expenses is estimated to increase to about 124.2 M, while Income Tax Expense is forecasted to increase to (2.2 M).
| 2023 | 2024 (projected) | Interest Income | 1.3M | 1.1M | Reconciled Depreciation | 1.1M | 740.0K |
Surgepays income statement Correlations
Click cells to compare fundamentals
Surgepays Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgepays income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (173.1K) | 4.2M | (1.3M) | 988.7K | 1.1M | 1.2M | |
| Interest Expense | 227.0K | 3.4M | 7.5M | 2.0M | 596.0K | 1.1M | |
| Selling General Administrative | 10.9M | 9.4M | 10.7M | 11.7M | 15.6M | 16.3M | |
| Other Operating Expenses | 32.5M | 62.8M | 57.0M | 120.9M | 118.3M | 124.2M | |
| Operating Income | (6.8M) | (8.4M) | (6.0M) | 873.7K | 18.9M | 19.8M | |
| Ebit | (6.8M) | (8.4M) | (6.0M) | 873.7K | 18.9M | 19.8M | |
| Ebitda | (7.0M) | (4.2M) | (7.3M) | 1.9M | 20.0M | 21.0M | |
| Total Operating Expenses | 12.2M | 10.9M | 12.2M | 12.8M | 15.7M | 16.5M | |
| Income Before Tax | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 18.4M | 19.3M | |
| Total Other Income Expense Net | (1.7M) | (2.3M) | (7.5M) | (1.4M) | (485.8K) | (510.1K) | |
| Net Income | (8.2M) | (16.9M) | (18.8M) | (148.9K) | 20.6M | 21.6M | |
| Income Tax Expense | (229.0K) | 6.2M | 5.3M | (404.4K) | (2.3M) | (2.2M) | |
| Total Revenue | 25.7M | 54.4M | 51.1M | 121.5M | 137.1M | 144.0M | |
| Gross Profit | 5.4M | 2.5M | 6.2M | 13.5M | 34.6M | 36.3M | |
| Cost Of Revenue | 20.3M | 51.9M | 44.9M | 108.1M | 102.6M | 107.7M | |
| Selling And Marketing Expenses | 1.1M | 273.0K | 661.2K | 259.4K | 152.9K | 145.2K | |
| Net Income From Continuing Ops | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 20.6M | 21.7M | |
| Net Income Applicable To Common Shares | (8.4M) | (10.7M) | (13.5M) | (680.8K) | (612.7K) | (643.3K) | |
| Net Interest Income | (227.0K) | (3.4M) | (7.5M) | (2.0M) | (596.0K) | (625.8K) | |
| Reconciled Depreciation | 55.6K | 1.4M | 917.5K | 988.7K | 1.1M | 740.0K |
Currently Active Assets on Macroaxis
| VWITX | Vanguard Intermediate Term Tax Exempt | |
| VGSTX | Vanguard Star Fund | |
| VFIAX | Vanguard 500 Index | |
| VTCLX | Vanguard Tax Managed Capital | |
| VTSAX | Vanguard Total Stock |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |
Is Surgepays' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.17) | Earnings Share 1.38 | Revenue Per Share 9.618 | Quarterly Revenue Growth (0.11) | Return On Assets 0.3106 |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.